Company · CIK 0001811063 · SIC 2834 — Pharmaceutical Preparations · NYSE
Nuvation Bio Inc. · NUVB
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 SForm 4 → | Aug 21, 4:49 pm EDT | Gary HattersleyCHIEF SCIENTIFIC OFFICER | 100,000 | $7.09 | $709,240 | 0 | −100% | 10b5-1 |
| Aug 19, 2026 MForm 4 → | Aug 21, 4:49 pm EDT | Gary HattersleyCHIEF SCIENTIFIC OFFICER | 100,000 | $1.87 | $187,000 | 100,000 | — | 10b5-1 |
| Jul 15, 2026 MForm 4 → | Jul 17, 6:27 pm EDT | Philippe SauvageChief Financial Officer | 40,000 | $2.17 | $86,800 | 54,131 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 MForm 4 → | Aug 21, 4:49 pm EDT | Gary HattersleyCHIEF SCIENTIFIC OFFICER | 100,000 | — | — | 400,000 | — | 10b5-1 |
| Jul 15, 2026 MForm 4 → | Jul 17, 6:27 pm EDT | Philippe SauvageChief Financial Officer | 40,000 | — | — | 499,999 | — |